Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: horizon shifting in advanced non-small cell lung cancer with immune check point inhibition

Saved in:

Bibliographic Details
Published in:	Ann Transl Med
Main Authors:	de Silva, Madhawa, Itchins, Malinda, Pavlakis, Nick
Format:	Artigo
Language:	Inglês
Published:	AME Publishing Company 2020
Subjects:	Editorial Commentary
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7214900/ https://ncbi.nlm.nih.gov/pubmed/32411778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.01.87
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items